Astri Therapeutics Inc (ATXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Operating Expenses | 28,803 | 24,150 | 34,199 | 20,236 | 15,102 |
Operating Income | -28,803 | -24,150 | -34,199 | -20,236 | -15,102 |
Other Income | 4,631 | 4,222 | 2,789 | 2,509 | 2,536 |
Pre-tax Income | -24,172 | -19,928 | -31,410 | -17,727 | -12,566 |
Net Income Continuous | -24,172 | -19,928 | -31,410 | -17,727 | -12,566 |
Net Income | $-24,172 | $-19,928 | $-31,410 | $-17,727 | $-12,566 |
EPS Basic Total Ops | -0.43 | -0.38 | -0.94 | -0.63 | -0.45 |
EPS Basic Continuous Ops | -0.43 | -0.38 | -0.94 | -0.63 | -0.45 |
EPS Diluted Total Ops | -0.43 | -0.38 | -0.94 | -0.63 | -0.45 |
EPS Diluted Continuous Ops | -0.43 | -0.38 | -0.94 | -0.63 | -0.45 |
EPS Diluted Before Non-Recurring Items | -0.43 | -0.38 | -0.86 | -0.63 | -0.45 |
EBITDA(a) | $-28,803 | $-24,150 | $-34,199 | $-20,236 | $-15,102 |